新冠疫情期糖尿病管理:混合方法研究揭示监测变化与影响
该混合方法研究基于加拿大初级保健数据库84 617例糖尿病患者,比较疫情前与疫情前21个月的HbA1c和血压监测频率及结果,并访谈19例患者。结果显示监测频率下降但均值稳定,患者通过自我管理和虚拟照护维持控制。
要点
- 疫情期间HbA1c检测不足1次者比例增加10%,血压测量不足1次者比例增加23%。
- 有检测者中,平均HbA1c和血压值保持临床稳定。
- 患者访谈提及虚拟照护、自我监测困难及自我管理策略。
核心结论
- 尽管监测频率降低,疫情期间平均HbA1c和血压值保持临床稳定,可能得益于照护连续性和患者自我管理。
研究设计与样本
- 两阶段混合方法研究:回顾性前后队列比较疫情前(2018年6月22日至2020年3月12日)与疫情期间(2020年3月13日至2021年12月3日)的监测频率和结果,并对19例患者进行半结构化访谈的定性描述分析。
主要发现
- 队列纳入84 617例符合验证糖尿病定义的惠者,疫情期间HbA1c检测不足1次者比例增加10%,血压测量不足1次者比例增加23%。
- 访谈19例患者讨论了虚拟照护、自我监测挑战及自我管理策略。
临床怎么用
- 部分糖尿病患者可能在较低监测强度下维持足够的糖尿病控制,可考虑照护去强化策略以缓解初级保健压力。
- 需关注并弥补疫情期间错过监测检测者的照护缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Canada, primary care manages most diabetes care. The COVID-19 pandemic disrupted primary care, reducing access to care and monitoring. OBJECTIVES: We aim to describe changes in diabetes monitoring during the first 21 months of the pandemic, patients' experiences with these changes, and impact on HbA1c and blood pressure (BP) control. METHODS: We conducted a two-phase mixed methods study: (i) A retrospective pre-post cohort study using de-identified electronic medical record data to compare HbA1c and BP measurement frequency and results in diabetic patients prepandemic (22 June 2018 to 12 March 2020) and during the pandemic (13 March 2020 to 3 December 2021); (ii) A qualitative descriptive analysis using semistructured interviews to understand patient experiences navigating diabetes care during the pandemic. RESULTS: The cohort included 84 617 patients with validated diabetes case definition. Proportion of patients with <1 HbA1c test increased by 10% during the pandemic. For those with ≥1 test, mean HbA1c remained unchanged [mean (SD) HbA1cPre: 7.2 (1.3); HbA1cDuring: 7.2 (1.3); P = .51]. Proportion of patients with <1 BP measurement increased by 23%. For those with ≥1 measurement, mean BP remained clinically similar [mean (SD) sBPPre: 131.8 (13.7); sBPDuring: 132.9 (15.2); P < .01. Mean dBPPre: 74.9 (8.6); dBPDuring: 75.1 (9.1); P = .63]. Nineteen participants were interviewed, discussing virtual care, challenges with self-monitoring, and self-management strategies. CONCLUSIONS: Mean HbA1c and BP values remained clinically stable during the pandemic despite reductions in monitoring frequency, likely due to continuity of care and patient self-management. Future research should evaluate a de-intensified frequency of diabetes monitoring and address care gaps. This study examined the impact of the COVID-19 pandemic on diabetes patients in Canada, focusing on changes in monitoring and management. Using de-identified medical record data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), a primary care research database, we compared HbA1c tests and in-office BP measurements from prepandemic to the first 21 months of the pandemic. We also conducted patient interviews to understand how their experiences managing diabetes evolved during the pandemic (compared to prepandemic). We found decreases in the frequency of both HbA1c tests and BP measurements during the pandemic. Despite this, blood sugar and BP remained stable for those who had tests done. Interviews revealed that many patients continued to receive ongoing diabetes monitoring throughout the pandemic, augmented by self-monitoring and self-management strategies like diet and exercise. Patients discussed strategies for managing BP and blood sugar, experiences with virtual care, difficulties accessing monitoring and healthcare, and challenges with self-monitoring equipment. These findings highlight that some patients may be able to maintain adequate diabetes control with less intensive monitoring. Strategies for care de-intensification could help relieve strain on primary care. Our results emphasize the need to ensure adequate care for those who missed monitoring tests during the pandemic.
引用
- Freeman K, Hafid S, Mangin D, et al. Primary care insights on the management of diabetes: results from a mixed method study of care changes and impacts during the COVID-19 pandemic. Fam Pract. 2025. PMID: 40510009. doi:10.1093/fampra/cmaf027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。